Market Cap 8.51B
Revenue (ttm) 39.21M
Net Income (ttm) -311.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -794.06%
Debt to Equity Ratio 0.00
Volume 511,800
Avg Vol 867,518
Day's Range N/A - N/A
Shares Out 82.26M
Stochastic %K 11%
Beta 1.95
Analysts Strong Sell
Price Target $126.83

Company Profile

Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing KT-621, an oral STAT6 degrader in Phase 2b clinical trials for moderate to severe atopic dermatitis, asthma, COPD, EoE, CRSwNP, CSU, PN, BP, and others; KT-579, an oral IRF5 degrader in Phase 1 trials for autoimmune disease...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 285 5300
Address:
500 North Beacon Street, 4th Floor, Watertown, United States
Ziggy2359
Ziggy2359 Aug. 2 at 8:42 PM
$KYMR This has some staying power
0 · Reply
Quantumup
Quantumup Jul. 28 at 11:10 AM
Guggenheim⬆️ $KYMR to $135 (was $125), reiterated Buy and said -- We think KYMR should be credited value if KT-579 shows healthy volunteer data in 2H26 that demonstrates safe >90% IRF5 degradation. $GSK $AUPH NVS RHHBY Here's what else Guggenheim had to say: https://x.com/Quantumup1/status/2082060908046479485?s=20
0 · Reply
IN0V8
IN0V8 Jul. 16 at 2:55 PM
$KYMR Mizuho raises target price to $140 from $120
0 · Reply
MikeyNJ
MikeyNJ Jul. 16 at 12:17 PM
$KYMR Mizuho raises price target to $140 from $120.
0 · Reply
bazza71
bazza71 Jul. 14 at 4:28 PM
$OTLK couldnt resist using a little profit to buy more $KYMR on the dip 😀 😜
0 · Reply
bazza71
bazza71 Jul. 13 at 5:24 PM
$KYMR Great opportunity to buy on the dip
0 · Reply
MooseG
MooseG Jul. 9 at 6:47 PM
$KYMR june 02 this was 71$.it has to come back down.
0 · Reply
MedicalDoctorInvestor
MedicalDoctorInvestor Jul. 9 at 12:17 PM
$KYMR Which company are you more bullish on for AD! The Doc wants to know. Vote now!
1 · Reply
justiceforb_85
justiceforb_85 Jul. 8 at 3:34 AM
$KYMR continues to show strength.
0 · Reply
MikeCaymanTrades
MikeCaymanTrades Jul. 4 at 9:59 PM
$KYMR The previous BUY signal was issued on 06/11/2026, 21 days ago, when the stock price was 81.43. Since then, KYMR has risen by +39.40%. 75.00 to 120.18 has to reclaim 130.00 that high wick.
0 · Reply
Latest News on KYMR
Kymera Therapeutics initiated with a Hold at Deutsche Bank

2026-07-30T08:20:13.000Z - 3 days ago

Kymera Therapeutics initiated with a Hold at Deutsche Bank


Biotech ETF Index Surges 10% After Rebalance

Jun 25, 2026, 11:31 AM EDT - 5 weeks ago

Biotech ETF Index Surges 10% After Rebalance

ALKS APGE DFTX DYN KLRA MANE MIRM


Kymera Therapeutics rises 18.6%

2026-06-25T14:05:50.000Z - 5 weeks ago

Kymera Therapeutics rises 18.6%


Kymera Therapeutics completes enrollment in BROADEN2 trial

2026-06-25T11:20:54.000Z - 5 weeks ago

Kymera Therapeutics completes enrollment in BROADEN2 trial


Kymera Therapeutics appoints Felix Baker as chairman

2026-06-24T20:11:14.000Z - 5 weeks ago

Kymera Therapeutics appoints Felix Baker as chairman


Kymera Therapeutics Appoints Felix J. Baker, Ph.D.

Jun 24, 2026, 4:01 PM EDT - 5 weeks ago

Kymera Therapeutics Appoints Felix J. Baker, Ph.D.


Kymera Therapeutics Transcript: AGM 2026

Jun 24, 2026, 8:30 AM EDT - 5 weeks ago

Kymera Therapeutics Transcript: AGM 2026


Kymera Therapeutics Slides: Corporate presentation

Jun 9, 2026, 7:00 AM EDT - 7 weeks ago

Kymera Therapeutics Slides: Corporate presentation


Kymera Therapeutics initiated with a Buy at Canaccord

2026-05-07T10:32:55.000Z - 3 months ago

Kymera Therapeutics initiated with a Buy at Canaccord


Kymera Therapeutics Earnings Call Transcript: Q1 2026

Apr 30, 2026, 8:30 AM EDT - 3 months ago

Kymera Therapeutics Earnings Call Transcript: Q1 2026


Kymera Therapeutics Earnings release: Q1 2026

Apr 30, 2026, 8:30 AM EDT - 3 months ago

Kymera Therapeutics Earnings release: Q1 2026


Kymera Therapeutics Quarterly report: Q1 2026

Apr 30, 2026, 8:30 AM EDT - 3 months ago

Kymera Therapeutics Quarterly report: Q1 2026


Kymera Therapeutics Slides: Q1 2026

Apr 30, 2026, 8:30 AM EDT - 3 months ago

Kymera Therapeutics Slides: Q1 2026


Kymera Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

Kymera Therapeutics Proxy statement: Proxy filing


Kymera Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

Kymera Therapeutics Proxy statement: Proxy filing


Kymera Therapeutics Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 5 months ago

Kymera Therapeutics Earnings Call Transcript: Q4 2025


Kymera Therapeutics Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 5 months ago

Kymera Therapeutics Annual report: Q4 2025


Kymera Therapeutics Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 5 months ago

Kymera Therapeutics Earnings release: Q4 2025


Kymera Therapeutics Slides: Q4 2025

Feb 26, 2026, 8:30 AM EST - 5 months ago

Kymera Therapeutics Slides: Q4 2025


Kymera Therapeutics Slides: Corporate presentation

Feb 26, 2026, 7:00 AM EST - 5 months ago

Kymera Therapeutics Slides: Corporate presentation


Kymera Therapeutics Announces Proposed Public Offering

Dec 8, 2025, 4:01 PM EST - 8 months ago

Kymera Therapeutics Announces Proposed Public Offering


This Drugmaker's Stock Is Soaring Over 40% Monday

Dec 8, 2025, 3:50 PM EST - 8 months ago

This Drugmaker's Stock Is Soaring Over 40% Monday


Kymera Therapeutics Transcript: Study Result

Dec 8, 2025, 8:00 AM EST - 8 months ago

Kymera Therapeutics Transcript: Study Result


Kymera Therapeutics Press release: Study Result

Dec 8, 2025, 8:00 AM EST - 8 months ago

Kymera Therapeutics Press release: Study Result


Kymera Therapeutics Slides: Study Result

Dec 8, 2025, 8:00 AM EST - 8 months ago

Kymera Therapeutics Slides: Study Result


Kymera Therapeutics Slides: Corporate Presentation

Nov 9, 2025, 6:00 PM EST - 9 months ago

Kymera Therapeutics Slides: Corporate Presentation


Kymera Therapeutics Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:30 AM EST - 9 months ago

Kymera Therapeutics Earnings Call Transcript: Q3 2025


Kymera Therapeutics Quarterly report: Q3 2025

Nov 4, 2025, 8:30 AM EST - 9 months ago

Kymera Therapeutics Quarterly report: Q3 2025


Kymera Therapeutics Earnings release: Q3 2025

Nov 4, 2025, 8:30 AM EST - 9 months ago

Kymera Therapeutics Earnings release: Q3 2025


Kymera Therapeutics Slides: Q3 2025

Nov 4, 2025, 8:30 AM EST - 9 months ago

Kymera Therapeutics Slides: Q3 2025


Kymera Therapeutics Slides: Corporate Presentation

Nov 3, 2025, 7:00 AM EST - 9 months ago

Kymera Therapeutics Slides: Corporate Presentation


The Best Small-Cap Stocks to Buy Now

Aug 12, 2025, 9:47 AM EDT - 1 year ago

The Best Small-Cap Stocks to Buy Now

DNLI WAY


Kymera Therapeutics Earnings Call Transcript: Q2 2025

Aug 11, 2025, 8:30 AM EDT - 1 year ago

Kymera Therapeutics Earnings Call Transcript: Q2 2025


Kymera Therapeutics Quarterly report: Q2 2025

Aug 11, 2025, 8:30 AM EDT - 1 year ago

Kymera Therapeutics Quarterly report: Q2 2025


Kymera Therapeutics Earnings release: Q2 2025

Aug 11, 2025, 8:30 AM EDT - 1 year ago

Kymera Therapeutics Earnings release: Q2 2025


Kymera Therapeutics Slides: Q2 2025

Aug 11, 2025, 8:30 AM EDT - 1 year ago

Kymera Therapeutics Slides: Q2 2025


Kymera Therapeutics Transcript: AGM 2025

Jun 25, 2025, 8:30 AM EDT - 1 year ago

Kymera Therapeutics Transcript: AGM 2025


Kymera Therapeutics Transcript: Study Result

Jun 2, 2025, 8:00 AM EDT - 1 year ago

Kymera Therapeutics Transcript: Study Result


Kymera Therapeutics Press release: Study Result

Jun 2, 2025, 8:00 AM EDT - 1 year ago

Kymera Therapeutics Press release: Study Result


Kymera Therapeutics Slides: Study Result

Jun 2, 2025, 8:00 AM EDT - 1 year ago

Kymera Therapeutics Slides: Study Result


Kymera Therapeutics Earnings Call Transcript: Q1 2025

May 9, 2025, 10:00 AM EDT - 1 year ago

Kymera Therapeutics Earnings Call Transcript: Q1 2025


Kymera Therapeutics Quarterly report: Q1 2025

May 9, 2025, 10:00 AM EDT - 1 year ago

Kymera Therapeutics Quarterly report: Q1 2025


Kymera Therapeutics Earnings release: Q1 2025

May 9, 2025, 10:00 AM EDT - 1 year ago

Kymera Therapeutics Earnings release: Q1 2025


Kymera Therapeutics Slides: Q1 2025

May 9, 2025, 10:00 AM EDT - 1 year ago

Kymera Therapeutics Slides: Q1 2025


Ziggy2359
Ziggy2359 Aug. 2 at 8:42 PM
$KYMR This has some staying power
0 · Reply
Quantumup
Quantumup Jul. 28 at 11:10 AM
Guggenheim⬆️ $KYMR to $135 (was $125), reiterated Buy and said -- We think KYMR should be credited value if KT-579 shows healthy volunteer data in 2H26 that demonstrates safe >90% IRF5 degradation. $GSK $AUPH NVS RHHBY Here's what else Guggenheim had to say: https://x.com/Quantumup1/status/2082060908046479485?s=20
0 · Reply
IN0V8
IN0V8 Jul. 16 at 2:55 PM
$KYMR Mizuho raises target price to $140 from $120
0 · Reply
MikeyNJ
MikeyNJ Jul. 16 at 12:17 PM
$KYMR Mizuho raises price target to $140 from $120.
0 · Reply
bazza71
bazza71 Jul. 14 at 4:28 PM
$OTLK couldnt resist using a little profit to buy more $KYMR on the dip 😀 😜
0 · Reply
bazza71
bazza71 Jul. 13 at 5:24 PM
$KYMR Great opportunity to buy on the dip
0 · Reply
MooseG
MooseG Jul. 9 at 6:47 PM
$KYMR june 02 this was 71$.it has to come back down.
0 · Reply
MedicalDoctorInvestor
MedicalDoctorInvestor Jul. 9 at 12:17 PM
$KYMR Which company are you more bullish on for AD! The Doc wants to know. Vote now!
1 · Reply
justiceforb_85
justiceforb_85 Jul. 8 at 3:34 AM
$KYMR continues to show strength.
0 · Reply
MikeCaymanTrades
MikeCaymanTrades Jul. 4 at 9:59 PM
$KYMR The previous BUY signal was issued on 06/11/2026, 21 days ago, when the stock price was 81.43. Since then, KYMR has risen by +39.40%. 75.00 to 120.18 has to reclaim 130.00 that high wick.
0 · Reply
MaverikIT
MaverikIT Jun. 30 at 1:50 PM
@Jblack500 @cynicaloptimist @No_Face_character @BustaCapital @WAJeff @IsabellaDC JB $ABVX just awesone $AXSM $NKTR $KYMR
1 · Reply
MikeyNJ
MikeyNJ Jun. 29 at 12:21 PM
$KYMR B. Riley raises price target to $155 from $117.
0 · Reply
RohR1
RohR1 Jun. 27 at 6:43 PM
$ORCL And then you have this. Top Insider Sells — Jun 26 $AVGO — Henry Samueli (Director) sold $250.0M $KYMR — Partners L P/Il Bvf (Director, See Remarks and Footnotes) sold $168.1M $ORCL — Jeffrey Henley (Director, Vice Chairman) sold $63.7M So. One of the key independent Board of Directors at ORCL sells $63 M of shares. Someone knew. In advance. And sold.
1 · Reply
MikeyNJ
MikeyNJ Jun. 26 at 3:04 PM
$KYMR Truist raises PT from $116 to $136.
0 · Reply
Quantumup
Quantumup Jun. 26 at 11:34 AM
B Riley⬆️ $KYMR-$155 and reiterated Buy CRVS APGE - $ABBV NKTR ORKA REGN $SNY GILD NRIX LLY Here's what B Riley had to say in its note to investors: https://x.com/Quantumup1/status/2070470389189267487?s=20
0 · Reply
StocktwitsNews
StocktwitsNews Jun. 25 at 11:58 PM
KYMR Stock Clocks Best Day In Over 6 Months On Advancing Eczema Trial Timeline $KYMR $VTI $VB https://stocktwits.com/news/equity/markets/kymr-stock-clocks-best-day-in-over-6-months-on-advancing-eczema-trial-timeline/cZ1GUNuR7Xr
0 · Reply
topstockalerts
topstockalerts Jun. 25 at 11:51 PM
$KYMR every dip getting scooped… kinda telling
0 · Reply
stu4
stu4 Jun. 25 at 9:40 PM
$CADL $SLS poor @MichToss99 , poor soul had to block the truth @jacksparo missed $KYMR back in the30’s , came to say he had this at $5 ! Always the way with a loser ! He never posted here…. ST is full of liars even TAK lol
0 · Reply
lecorb
lecorb Jun. 25 at 4:54 PM
$MU $SNDK $TECH $BB $KYMR 👏🏼👏🏼👏🏼👊🏻👊🏻👊🏻
0 · Reply
IsabellaDC
IsabellaDC Jun. 25 at 3:49 PM
All time high scan: $KYMR $MU $ALMR $ASND $GLW and so on.
0 · Reply
FGB1
FGB1 Jun. 25 at 3:23 PM
$KYMR what did i miss?…… why is this thing blowing up today? All my degrader companies (KYMR, NRIX and GLUE) are up huge today!
0 · Reply
topstockalerts
topstockalerts Jun. 25 at 2:38 PM
Top Gainers PT2 $IQST $FCUV $KYMR $WYY $MEI
0 · Reply